Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick F Kiser

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Pharmaceutics|April 23, 2011
Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticlesMeredith R Clark, Hyder A Aliyar, Chang-won Lee, et al.
Journal of Pharmaceutical Sciences|July 8, 2015
An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV TransmissionShweta R Ugaonkar, Justin T Clark, Lexie B English, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2012
Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovirJustin T Clark, Todd J Johnson, Meredith R Clark, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure ProphylaxisEkaterina Taneva, Kerry Crooker, Sung Hyun Park, et al.
Plos One|March 7, 2014
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancyJustin T Clark, Meredith R Clark, Namdev B Shelke, et al.
AIDS Research and Human Retroviruses|March 5, 2016
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product DesignKate Morrow Guthrie, Shira Dunsiger, Sara E Vargas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 21, 2020
Design and Testing of a Cabotegravir Implant for HIV PreventionDipu Karunakaran, Solange M Simpson, Jonathan T Su, et al.
AIDS and Behavior|November 20, 2013
"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gelsJacob J van den Berg, Rochelle K Rosen, Dana E Bregman, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal ringsTodd J Johnson, Priya Srinivasan, Theodore H Albright, et al.
Retrovirology|October 26, 2013
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary propertiesPedro M M Mesquita, Priya Srinivasan, Todd J Johnson, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Pharmaceutics|April 23, 2011
Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticlesMeredith R Clark, Hyder A Aliyar, Chang-won Lee, et al.
Journal of Pharmaceutical Sciences|July 8, 2015
An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV TransmissionShweta R Ugaonkar, Justin T Clark, Lexie B English, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2012
Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovirJustin T Clark, Todd J Johnson, Meredith R Clark, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure ProphylaxisEkaterina Taneva, Kerry Crooker, Sung Hyun Park, et al.
Plos One|March 7, 2014
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancyJustin T Clark, Meredith R Clark, Namdev B Shelke, et al.
AIDS Research and Human Retroviruses|March 5, 2016
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product DesignKate Morrow Guthrie, Shira Dunsiger, Sara E Vargas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 21, 2020
Design and Testing of a Cabotegravir Implant for HIV PreventionDipu Karunakaran, Solange M Simpson, Jonathan T Su, et al.
AIDS and Behavior|November 20, 2013
"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gelsJacob J van den Berg, Rochelle K Rosen, Dana E Bregman, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal ringsTodd J Johnson, Priya Srinivasan, Theodore H Albright, et al.
Retrovirology|October 26, 2013
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary propertiesPedro M M Mesquita, Priya Srinivasan, Todd J Johnson, et al.
Pageof 6